Opposing actions of fibroblast and cardiomyocyte smad3 signaling in the infarcted myocardium

Circulation

Volumn 137, Issue 7, 2018, Pages 707-724

  Kong, Ping ^a   Shinde, Arti V ^a   Su, Ya ^a   Russo, Ilaria ^a   Chen, Bijun ^a   Saxena, Amit ^a   Conway, Simon J ^b   Graff, Jonathan M ^c   Frangogiannis, Nikolaos G ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cardiomyocyte; Fibroblast; Heart failure; Remodeling; Smad

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; SMAD3 PROTEIN; CYBB PROTEIN, MOUSE; GELATINASE A; INTEGRIN; MMP2 PROTEIN, MOUSE; OXYGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SMAD3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC MUSCLE CELL; CELL ISOLATION; CELL PROLIFERATION; CELL SPECIFICITY; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FIBROBLAST; GENE EXPRESSION LEVEL; HEART INFARCTION; HEART MUSCLE REPERFUSION; IN VITRO STUDY; INCIDENCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; FIBROBLASTS; INTEGRINS; MATRIX METALLOPROTEINASE 2; MICE; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NADPH OXIDASE 2; OXYGEN; SIGNAL TRANSDUCTION; SMAD3 PROTEIN;

EID: 85047727680     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.117.029622     Document Type: Article

References (50)

1. Deten A, Hölzl A, Leicht M, Barth W, Zimmer HG, Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. J Mol Cell Cardiol 2001 33 1191 1207. doi: 10.1006/jmcc.2001.1383.
2. Dewald O, Ren G, Duerr GD, Zoerlein M, Klemm C, Gersch C, Tincey S, Michael LH, Entman ML, Frangogiannis NG, Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. Am J Pathol 2004 164 665 677. doi: 10.1016/S0002-9440(10)63154-9.
3. Hao J, Ju H, Zhao S, Junaid A, Scammell-La Fleur T, Dixon IM, Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. J Mol Cell Cardiol 1999 31 667 678. doi: 10.1006/jmcc.1998.0902.
4. Bujak M, Ren G, Kweon HJ, Dobaczewski M, Reddy A, Taffet G, Wang XF, Frangogiannis NG, Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation 2007 116 2127 2138. doi: 10.1161/CIRCULATIONAHA.107.704197.
5. Dobaczewski M, Bujak M, Li N, Gonzalez-Quesada C, Mendoza LH, Wang XF, Frangogiannis NG, Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. Circ Res 2010 107 418 428. doi: 10.1161/CIRCRESAHA.109.216101.
6. Li Q, Pangas SA, Jorgez CJ, Graff JM, Weinstein M, Matzuk MM, Redundant roles of SMAD2 and SMAD3 in ovarian granulosa cells in vivo. Mol Cell Biol 2008 28 7001 7011. doi: 10.1128/MCB.00732-08.
7. Lindsley A, Snider P, Zhou H, Rogers R, Wang J, Olaopa M, Kruzynska-Frejtag A, Koushik SV, Lilly B, Burch JB, Firulli AB, Conway SJ, Identification and characterization of a novel Schwann and outflow tract endocardial cushion lineage-restricted periostin enhancer. Dev Biol 2007 307 340 355. doi: 10.1016/j.ydbio.2007.04.041.
8. Conway SJ, Molkentin JD, Periostin as a heterofunctional regulator of cardiac development and disease. Curr Genomics 2008 9 548 555. doi: 10.2174/138920208786847917.
9. Kong P, Christia P, Saxena A, Su Y, Frangogiannis NG, Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis. Am J Physiol Heart Circ Physiol 2013 305 H1363 H1372. doi: 10.1152/ajpheart.00395.2013.
10. Oka T, Maillet M, Watt AJ, Schwartz RJ, Aronow BJ, Duncan SA, Molkentin JD, Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ Res 2006 98 837 845. doi: 10.1161/01.RES.0000215985.18538.c4.
11. Bujak M, Dobaczewski M, Gonzalez-Quesada C, Xia Y, Leucker T, Zymek P, Veeranna V, Tager AM, Luster AD, Frangogiannis NG, Induction of the CXC chemokine interferon-gamma-inducible protein 10 regulates the reparative response following myocardial infarction. Circ Res 2009 105 973 983. doi: 10.1161/CIRCRESAHA.109.199471.
12. Takeda N, Manabe I, Uchino Y, Eguchi K, Matsumoto S, Nishimura S, Shindo T, Sano M, Otsu K, Snider P, Conway SJ, Nagai R, Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J Clin Invest 2010 120 254 265. doi: 10.1172/JCI40295.
13. Lal H, Ahmad F, Zhou J, Yu JE, Vagnozzi RJ, Guo Y, Yu D, Tsai EJ, Woodgett J, Gao E, Force T, Cardiac fibroblast glycogen synthase kinase-3β regulates ventricular remodeling and dysfunction in ischemic heart. Circulation 2014 130 419 430. doi: 10.1161/CIRCULATIONAHA.113.008364.
14. Hinz B, The myofibroblast: paradigm for a mechanically active cell. J Biomech 2010 43 146 155. doi: 10.1016/j.jbiomech.2009.09.020.
15. Hinz B, Celetta G, Tomasek JJ, Gabbiani G, Chaponnier C, Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 2001 12 2730 2741
16. Shinde AV, Humeres C, Frangogiannis NG, The role of-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling. Biochim Biophys Acta 2017 1863 298 309. doi: 10.1016/j.bbadis.2016.11.006.
17. Siani A, Tirelli N, Myofibroblast differentiation: main features, biomedical relevance, and the role of reactive oxygen species. Antioxid Redox Signal 2014 21 768 785. doi: 10.1089/ars.2013.5724.
18. Leask A, Integrin β1: A mechanosignaling sensor essential for connective tissue deposition by fibroblasts. Adv Wound Care (New Rochelle) 2013 2 160 166. doi: 10.1089/wound.2012.0365.
19. Schröder D, Heger J, Piper HM, Euler G, Angiotensin II stimulates apoptosis via TGF-beta1 signaling in ventricular cardiomyocytes of rat. J Mol Med (Berl) 2006 84 975 983. doi: 10.1007/s00109-006-0090-0.
20. Meischl C, Krijnen PA, Sipkens JA, Cillessen SA, Muñoz IG, Okroj M, Ramska M, Muller A, Visser CA, Musters RJ, Simonides WS, Hack CE, Roos D, Niessen HW, Ischemia induces nuclear NOX2 expression in cardiomyocytes and subsequently activates apoptosis. Apoptosis 2006 11 913 921. doi: 10.1007/s10495-006-6304-7.
21. Spinale FG, Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 2007 87 1285 1342. doi: 10.1152/physrev.00012.2007.
22. Lindsey ML, Gannon J, Aikawa M, Schoen FJ, Rabkin E, Lopresti-Morrow L, Crawford J, Black S, Libby P, Mitchell PG, Lee RT, Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction. Circulation 2002 105 753 758
23. Wang Y, Ait-Oufella H, Herbin O, Bonnin P, Ramkhelawon B, Taleb S, Huang J, Offenstadt G, Combadière C, Rénia L, Johnson JL, Tharaux PL, Tedgui A, Mallat Z, TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. J Clin Invest 2010 120 422 432. doi: 10.1172/JCI38136.
24. Yuan W, Varga J, Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3. J Biol Chem 2001 276 38502 38510. doi: 10.1074/jbc.M107081200.
25. Saxena A, Chen W, Su Y, Rai V, Uche OU, Li N, Frangogiannis NG, IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium. J Immunol 2013 191 4838 4848. doi: 10.4049/jimmunol.1300725.
26. Aisagbonhi O, Rai M, Ryzhov S, Atria N, Feoktistov I, Hatzopoulos AK, Experimental myocardial infarction triggers canonical Wnt signaling and endothelial-To-mesenchymal transition. Dis Model Mech 2011 4 469 483. doi: 10.1242/dmm.006510.
27. Ruiz-Villalba A, Simón AM, Pogontke C, Castillo MI, Abizanda G, Pelacho B, Sánchez-Domínguez R, Segovia JC, Prósper F, Pérez-Pomares JM, Interacting resident epicardium-derived fibroblasts and recruited bone marrow cells form myocardial infarction scar. J Am Coll Cardiol 2015 65 2057 2066. doi: 10.1016/j.jacc.2015.03.520.
28. Willems IE, Havenith MG, De Mey JG, Daemen MJ, The alpha-smooth muscle actin-positive cells in healing human myocardial scars. Am J Pathol 1994 145 868 875
29. Blankesteijn WM, Essers-Janssen YP, Verluyten MJ, Daemen MJ, Smits JF, A homologue of Drosophila tissue polarity gene frizzled is expressed in migrating myofibroblasts in the infarcted rat heart. Nat Med 1997 3 541 544
30. Furtado MB, Costa MW, Pranoto EA, Salimova E, Pinto AR, Lam NT, Park A, Snider P, Chandran A, Harvey RP, Boyd R, Conway SJ, Pearson J, Kaye DM, Rosenthal NA, Cardiogenic genes expressed in cardiac fibroblasts contribute to heart development and repair. Circ Res 2014 114 1422 1434. doi: 10.1161/CIRCRESAHA.114.302530.
31. Bang C, Batkai S, Dangwal S, Gupta SK, Foinquinos A, Holzmann A, Just A, Remke J, Zimmer K, Zeug A, Ponimaskin E, Schmiedl A, Yin X, Mayr M, Halder R, Fischer A, Engelhardt S, Wei Y, Schober A, Fiedler J, Thum T, Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest 2014 124 2136 2146. doi: 10.1172/JCI70577.
32. Birdsall HH, Green DM, Trial J, Youker KA, Burns AR, MacKay CR, LaRosa GJ, Hawkins HK, Smith CW, Michael LH, Entman ML, Rossen RD, Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion. Circulation 1997 95 684 692
33. Desmoulière A, Geinoz A, Gabbiani F, Gabbiani G, Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993 122 103 111
34. Davis J, Burr AR, Davis GF, Birnbaumer L, Molkentin JD, A TRPC6-dependent pathway for myofibroblast transdifferentiation and wound healing in vivo. Dev Cell 2012 23 705 715. doi: 10.1016/j.devcel.2012.08.017.
35. Molkentin JD, Bugg D, Ghearing N, Dorn LE, Kim P, Sargent MA, Gunaje J, Otsu K, Davis J, Fibroblast-specific genetic manipulation of p38 mitogen-Activated protein kinase in vivo reveals its central regulatory role in fibrosis. Circulation 2017 136 549 561. doi: 10.1161/CIRCULATIONAHA.116.026238.
36. Schroer AK, Merryman WD, Mechanobiology of myofibroblast adhesion in fibrotic cardiac disease. J Cell Sci 2015 128 1865 1875. doi: 10.1242/jcs.162891.
37. Goldsmith EC, Bradshaw AD, Zile MR, Spinale FG, Myocardial fibroblast-matrix interactions and potential therapeutic targets. J Mol Cell Cardiol 2014 70 92 99. doi: 10.1016/j.yjmcc.2014.01.008.
38. Chen X, Wang H, Liao HJ, Hu W, Gewin L, Mernaugh G, Zhang S, Zhang ZY, Vega-Montoto L, Vanacore RM, Fässler R, Zent R, Pozzi A, Integrin-mediated type II TGF-β receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling. J Clin Invest 2014 124 3295 3310. doi: 10.1172/JCI71668.
39. Sangrar W, Gao Y, Scott M, Truesdell P, Greer PA, Fer-mediated cortactin phosphorylation is associated with efficient fibroblast migration and is dependent on reactive oxygen species generation during integrin-mediated cell adhesion. Mol Cell Biol 2007 27 6140 6152. doi: 10.1128/MCB.01744-06.
40. Kheradmand F, Werner E, Tremble P, Symons M, Werb Z, Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change. Science 1998 280 898 902
41. Su SA, Yang D, Wu Y, Xie Y, Zhu W, Cai Z, Shen J, Fu Z, Wang Y, Jia L, Wang Y, Wang JA, Xiang M, EphrinB2 regulates cardiac fibrosis through modulating the interaction of Stat3 and TGF-β/Smad3 signaling. Circ Res 2017 121 617 627. doi: 10.1161/CIRCRESAHA.117.311045.
42. Heger J, Warga B, Meyering B, Abdallah Y, Schlüter KD, Piper HM, Euler G, TGFβ receptor activation enhances cardiac apoptosis via SMAD activation and concomitant NO release. J Cell Physiol 2011 226 2683 2690. doi: 10.1002/jcp.22619.
43. Baxter GF, Mocanu MM, Brar BK, Latchman DS, Yellon DM, Cardioprotective effects of transforming growth factor-beta1 during early reoxygenation or reperfusion are mediated by p42/p44 MAPK. J Cardiovasc Pharmacol 2001 38 930 939
44. Rainer PP, Hao S, Vanhoutte D, Lee DI, Koitabashi N, Molkentin JD, Kass DA, Cardiomyocyte-specific transforming growth factor β suppression blocks neutrophil infiltration, augments multiple cytoprotective cascades, and reduces early mortality after myocardial infarction. Circ Res 2014 114 1246 1257. doi: 10.1161/CIRCRESAHA.114.302653.
45. Li S, Tao L, Jiao X, Liu H, Cao Y, Lopez B, Luan RH, Christopher T, Ma XL, TNFalpha-initiated oxidative/nitrative stress mediates cardiomyocyte apoptosis in traumatic animals. Apoptosis 2007 12 1795 1802. doi: 10.1007/s10495-007-0108-2.
46. Awad AE, Kandalam V, Chakrabarti S, Wang X, Penninger JM, Davidge ST, Oudit GY, Kassiri Z, Tumor necrosis factor induces matrix metalloproteinases in cardiomyocytes and cardiofibroblasts differentially via superoxide production in a PI3Kgamma-dependent manner. Am J Physiol Cell Physiol 2010 298 C679 C692. doi: 10.1152/ajpcell.00351.2009.
47. León H, Baczkó I, Sawicki G, Light PE, Schulz R, Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte. Br J Pharmacol 2008 153 676 683. doi: 10.1038/sj.bjp.0707621.
48. Ali MA, Cho WJ, Hudson B, Kassiri Z, Granzier H, Schulz R, Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury. Circulation 2010 122 2039 2047. doi: 10.1161/CIRCULATIONAHA.109.930222.
49. Koitabashi N, Danner T, Zaiman AL, Pinto YM, Rowell J, Mankowski J, Zhang D, Nakamura T, Takimoto E, Kass DA, Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload. J Clin Invest 2011 121 2301 2312. doi: 10.1172/JCI44824.
50. Khalil H, Kanisicak O, Prasad V, Correll RN, Fu X, Schips T, Vagnozzi RJ, Liu R, Huynh T, Lee SJ, Karch J, Molkentin JD, Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis. J Clin Invest 2017 127 3770 3783. doi: 10.1172/JCI94753.